R., M., P., P. H. and R., M. H. (2016) “A prospective analysis of the cost-effectiveness of alfuzosin, tamsulosin and silodosin for 12 weeks in benign prostatic hyperplasia”, International Journal of Basic & Clinical Pharmacology, 5(6), pp. 2481–2487. doi: 10.18203/2319-2003.ijbcp20164109.